Quarterly report pursuant to Section 13 or 15(d)

Retatement of Previously Issued Financial Statements - Schedule of Condensed Consolidated Financial Statements (Details) (Parenthetical)

v3.7.0.1
Retatement of Previously Issued Financial Statements - Schedule of Condensed Consolidated Financial Statements (Details) (Parenthetical) - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Accounts receivable, allowance $ 494,011 $ 492,498 $ 492,498 $ 492,498 $ 524,565 $ 524,565 $ 518,657
Preferred stock, par value $ .01 $ 0.01 $ 0.01 $ .01 $ 0.01 $ 0.01 $ 0.01
Preferred stock, shares authorized 500,000 500,000 500,000 500,000 500,000 500,000 500,000
Common stock, par value $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock, shares authorized 14,500,000 14,500,000 14,500,000 14,500,000 14,500,000 14,500,000 14,500,000
Common stock, shares issued 11,132,349 10,993,054 10,882,281 10,713,372 10,418,350 10,322,826 10,307,826
Common stock, shares outstanding 11,097,570 10,958,275 10,855,002 10,686,093 10,391,071 10,295,547 10,280,547
Treasury stock, shares 34,779 34,779 27,279 27,279 27,279 27,279 27,279
As Originally Presented [Member]              
Accounts receivable, allowance   $ 495,760 $ 500,853   $ 487,937 $ 518,657